Kaplan Fox Reminds Investors with Losses in Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) of February 3, 2023 Lead Plaintiff Deadline
13 janv. 2023 23h00 HE
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) filed a proposed class action suit in the United States District Court for the Southern District of...
Kaplan Fox Files Class Action to Recover Losses for Investors Who Purchased Common Stock of Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI)
05 déc. 2022 21h40 HE
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has filed a proposed class action suit in the United States District Court for the Southern District...